Ross Muken
Tracked across 3 events · 22 articles · First seen May 13, 2026 · Last active Aug 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Ross Muken is appointed as the new Chief Executive Officer of Sophia Genetics, effective July 1, 2026, bringing extensive experience to lead the company's next phase of growth.
Jun 10, 2026 · 7 articles
Business
Impact: Ross Muken, as CEO of Sophia Genetics, is the public spokesperson for the collaboration, and his leadership is instrumental in executing the partnership, though the event's impact on him personally is indirect.
Aug 04, 2026 · 8 articles
Business
Impact: Ross Muken, President of Sophia Genetics, highlighted the significance of the partnership for scaling liquid biopsy within Bret Engemann.
May 13, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Ross Muken live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard